Previous studies demonstrated that the use of Tempol, an anti-oxidant, prevents obesity in mice through the reduction of BSH activity, resulting in FXR inhibition via the accumulation of tauro-β-muricholic acid. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.